Legal & General Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $49.3K | Hold |
|
|||||
|
2025
Q2 | $41.6K | Sell |
|
|||||
|
2025
Q1 | $60.7K | Sell |
|
|||||
|
2024
Q4 | $506K | Buy |
|
|||||
|
2024
Q3 | $1.69M | Hold |
|
|||||
|
2024
Q2 | $1.33M | Buy |
|
|||||
|
2024
Q1 | $1.69M | Buy |
|
|||||
|
2023
Q4 | $751K | Sell |
|
|||||
|
2023
Q3 | $603K | Buy |
|
|||||
|
2023
Q2 | $727K | Buy |
|
|||||
|
2023
Q1 | $408K | Buy |
|
|||||
|
2022
Q4 | $388K | Buy |
|
|||||
|
2022
Q3 | $287K | Buy |
|
|||||
|
2022
Q2 | $190K | Buy |
|
|||||
|
2022
Q1 | $373K | Buy |
|
|||||
|
2021
Q4 | $360K | Buy |
|
|||||
|
2021
Q3 | $243K | Buy |
|
|||||
|
2021
Q2 | $154K | Buy |
|
|||||
|
2021
Q1 | $211K | Sell |
|
|||||
|
2020
Q4 | $245K | Buy |
|
|||||
|
2020
Q3 | $32K | Sell |
|
|||||
|
2020
Q2 | $42K | Buy |
|